HPV vaccination initiation after the routine-recommended ages of 11–12 in the United States

by Daniel C. Beachler, Felisa A. Gonzales, Sarah C. Kobrin, Aimée R. Kreimer
Published 2016-12-01

Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.

by Ruth M Pfeiffer, Yikyung Park, Aimée R Kreimer, James V Lacey, David Pee, Robert T Greenlee, Saundra S Buys, Albert Hollenbeck, Bernard Rosner, Mitchell H Gail, Patricia Hartge
Published 2013-01-01

HPV16 E6 seropositivity among cancer-free men with oral, anal or genital HPV16 infection

by Daniel C. Beachler, Tim Waterboer, Christine M. Pierce Campbell, Donna J. Ingles, Krystle A. Lang Kuhs, Alan G. Nyitray, Allan Hildesheim, Michael Pawlita, Aimée R. Kreimer, Anna R. Giuliano
Published 2016-12-01

Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica.

by Rolando Herrero, Wim Quint, Allan Hildesheim, Paula Gonzalez, Linda Struijk, Hormuzd A Katki, Carolina Porras, Mark Schiffman, Ana Cecilia Rodriguez, Diane Solomon, Silvia Jimenez, John T Schiller, Douglas R Lowy, Leen-Jan van Doorn, Sholom Wacholder, Aimée R Kreimer, CVT Vaccine Group
Published 2013-01-01